NCT05559879 2025-05-04Cabozantinib and Dostarlimab in Recurrent Gynecologic CarcinosarcomaUniversity of Alabama at BirminghamPhase 1/2 Recruiting37 enrolled
NCT04300140 2023-10-30Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced or Metastatic Clear Cell Renal Cell CarcinomaAravive, Inc.Phase 1/2 Terminated72 enrolled